Invention Grant
US09586992B2 Amidated dopamine neuron stimulating peptides for CNS dopaminergic upregulation
有权
用于CNS多巴胺能上调的氨基酸多巴胺神经元刺激肽
- Patent Title: Amidated dopamine neuron stimulating peptides for CNS dopaminergic upregulation
- Patent Title (中): 用于CNS多巴胺能上调的氨基酸多巴胺神经元刺激肽
-
Application No.: US14153844Application Date: 2014-01-13
-
Publication No.: US09586992B2Publication Date: 2017-03-07
- Inventor: Luke Bradley , Don Marshall Gash , Greg Gerhardt
- Applicant: University of Kentucky Research Foundation
- Applicant Address: US KY Lexington
- Assignee: University of Kentucky Research Foundation
- Current Assignee: University of Kentucky Research Foundation
- Current Assignee Address: US KY Lexington
- Agency: Crowell & Moring LLP
- Main IPC: C07K7/06
- IPC: C07K7/06 ; A61K38/08 ; A61K38/10 ; C07K7/08
Abstract:
The present invention relates to novel proteins, referred to herein as amidated glial cell line-derived neurotrophic factor (GDNF) peptides (or “Amidated Dopamine Neuron Stimulating peptides (ADNS peptides)”), that are useful for treating brain diseases and injuries that result in dopaminergic deficiencies.
Public/Granted literature
- US20140148393A1 Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation Public/Granted day:2014-05-29
Information query
